InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Simpson Adam K., Chairman & CEO. Director active across 1 companies, notably Icosavax, Inc.. Cumulatively, 6 reports have been published. The latest transaction was disclosed on 28 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€3,6594,789 shares@ €0.76410.1% of flow
Common Stock
SEC:0001209191-22-021658:0·
075,578 shares0
Common Stock
SEC:0001209191-22-009528:0·
€12,45716,764 shares@ €0.74310.4% of flow
Common Stock
SEC:0001209191-22-005478:0·
€12,45716,764 shares@ €0.74310.8% of flow
Common Stock
SEC:0001209191-22-005478·
€2m125,000 shares@ €12.612599.2% of flow
Common Stock
SEC:0000899243-21-031140·
€2m125,000 shares@ €12.612549.6% of flow
Common Stock
SEC:0000899243-21-031140:0·
6 of 6 declarations
About Simpson Adam K.
Simpson Adam K. is the Chief Executive Officer of Icosavax, Inc. In this role, he is responsible for the strategic and operational leadership of the company. His expertise in biopharmaceutical product development and ability to lead teams are essential for achieving Icosavax's growth and innovation objectives.
